About
Markus Gemuend is a biopharmaceutical executive with over twenty years of experience developing vaccines and biologics from early development through global commercialization. He has held leadership roles across R&D, operations, and market introduction at both multinational pharmaceutical companies and global health organizations. As a Senior Advisor at Adjuvant Capital, he advises on industrialization strategies, technology transfer, and partnerships aimed at expanding access to health products.
Invests in
BiotechDigital HealthImpact & Social Good
Experience
- BAMCO AfricaCo-Founder and CEOcurrent2023 — present
- Maximize Meaningful Education(M2E) FoundationCo-Founder and Chairmancurrent2012 — presentMusanze, Rwanda and San Francisco, CA, USA
- MalaicaBoard Membercurrent2022 — presentNairobi, Kenya
- University of California, RiversideAdvisory Board Member - Transformative Leadership in Disruptive Timescurrent2023 — present
- GenentechExecutive Director2021 — 2022South San Francisco, California, United States
- RocheHead of French and Portuguese Speaking Countries in Sub-Saharan Africa2019 — 2021Abidjan, Côte d’Ivoire
- RocheHead of Sub Saharan Africa Sub-Region2016 — 2020Lagos, Nigeria
- RocheGlobal Head of Roche Pharma Procurement2010 — 2016San Francisco, CA, USA and Basel, Switzerland
- GENENTECH FOUNDATIONBoard Member2005 — 2016San Francisco, California, United States
- GenentechGlobal Head of Biologics Manufacturing Genentech/Roche2007 — 2010South San Francisco, California
- GenentechHead of Contract Manufacturing and Manufacturing Collaborations2004 — 2007South San Francisco, California
- LonzaCEO2002 — 2004Basel, Switzerland
- LonzaHead of Lonza Biologics2001 — 2004Portsmouth, NH
- LonzaBusiness Head Small Molecules NA1998 — 2001Fair Lawn, New Jersey
- LonzaLegal Counsel1988 — 1998Basel, Switzerland
Skills & more
Biotechnology8Cross-functional Team Leadership13Pharmaceutical Industry11Strategic Planning7Strategy6FDA1
From Markus's professional profile.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital
Frequently asked questions
- Who is Markus Gemuend?
- Markus Gemuend is a biopharmaceutical executive with over twenty years of experience developing vaccines and biologics from early development through global commercialization. He has held leadership roles across R&D, operations, and market introduction at both multinational pharmaceutical companies and global health organizations. As a Senior Advisor at Adjuvant Capital, he advises on industrialization strategies, technology transfer, and partnerships aimed at expanding access to health products.
- Where does Markus Gemuend work?
- Markus Gemuend is Senior Advisor at Adjuvant Capital.
- What does Markus Gemuend invest in?
- Markus Gemuend invests in Biotech, Digital Health, Impact & Social Good.
- Where did Markus Gemuend go to school?
- Markus Gemuend studied at University of Basel (Law).
Same school
Also attended University of Basel25
Christina UlardicPartner at Astanor VenturesButrint AliuAnalyst at Pureos BioventuresNadine KuglerHead of Tech Communications at QAI VenturesDavide OttoliniCo-founder at Korify CapitalRobin LauberInvestor at Korify CapitalJonathan KirschnerSenior Advisor at Blue Haven Initiative
+ 19 more
Shared employers
Also worked at Genentech124
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 118 more
Also worked at Roche109
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersJules D'AssonvilleCo-Founder at InnoCom Bio Equities
+ 103 more
Also worked at Lonza7
Brad MorieSenior Director, Biotechnologies at Research Corporation TechnologiesBenoit DubuisSwitzerland Board Member at MassChallenge MexicoPatrick StragierInvestment Manager at Meusinvest (Noshaq)Philippe StasInvestor at White FundAnísHead of Scoping, Pharma at Deep Science VenturesUplaksh KumarVenture Partner at Foresite Capital
+ 1 more